Your browser doesn't support javascript.
loading
Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A.
Lysenkova, Lyudmila N; Saveljev, Oleg Y; Grammatikova, Natalya E; Tsvetkov, Vladimir B; Bekker, Olga B; Danilenko, Valery N; Dezhenkova, Lyubov G; Bykov, Eugene E; Omelchuk, Olga A; Korolev, Alexander M; Shchekotikhin, Andrey E.
Afiliação
  • Lysenkova LN; G. F. Gause Institute of New Antibiotics, Moscow, Russian Federation.
  • Saveljev OY; M. V. Lomonosov Moscow State University, Moscow, Russian Federation.
  • Grammatikova NE; G. F. Gause Institute of New Antibiotics, Moscow, Russian Federation.
  • Tsvetkov VB; A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, Moscow, Russian Federation.
  • Bekker OB; Institute for Physical-Chemical Medicine, Moscow, Russian Federation.
  • Danilenko VN; Research Institute of Influenza, St-Petersburg, Russian Federation.
  • Dezhenkova LG; N. I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russian Federation.
  • Bykov EE; N. I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow, Russian Federation.
  • Omelchuk OA; G. F. Gause Institute of New Antibiotics, Moscow, Russian Federation.
  • Korolev AM; G. F. Gause Institute of New Antibiotics, Moscow, Russian Federation.
  • Shchekotikhin AE; G. F. Gause Institute of New Antibiotics, Moscow, Russian Federation.
J Antibiot (Tokyo) ; 70(8): 871-877, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28420869
Although, the structure of oligomycin A (1) was confirmed by spectroscopic and chemical evaluations, some crystallographic data cast doubt on the originally adopted structure of the side 2-hydroxypropyl moiety of this antibiotic. It was suggested that the side chain of the oligomycin is enol-related (2-hydroxy-1-propenyl). To clarify this matter we synthesized and evaluated 33-dehydrooligomycin A (2) prepared by the Kornblum oxidation of 33-O-mesyloligomycin A (3) by dimethyl sulfoxide. NMR data for 33-dehydrooligomycin (2) and results of quantum chemical calculations have shown that this derivative exists in the keto rather than in the enol tautomer 2a. The in vitro antimicrobial activity of 2 was approximately two times weaker in comparison with oligomycin A against Streptomyces fradiae ATCC-19609 and reference Candida spp. strains and similar activity against certain filamentous fungi. The docking binding estimate of 2 with FOF1ATP synthase showed a slight decrease in binding affinity for 2 when compared with oligomycin A; that correlated with its activity against S. fradiae ATCC 19609 that is supersensitive to oligomycin A. The in vitro antiproliferative activities of 2 are also discussed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligomicinas / Antibacterianos / Antifúngicos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligomicinas / Antibacterianos / Antifúngicos / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article